Sep 16, 2019 / 08:00AM GMT
Operator
Ladies and gentlemen, welcome to the H. Lundbeck conference call. (Operator Instructions) Today, I am pleased to present Deborah Dunsire, President and CEO; and Anders Götzsche, Executive Vice President and CFO; and Johan Luthman, Executive Vice President of Research and Development. Speakers, please begin your meeting.
Deborah Dunsire - H. Lundbeck A/S-President&CEO
Thank you very much, operator, and thank you for joining us to discuss the announcement today of our agreement to acquire Alder BioPharmaceuticals. I hope you have received our press release and can see the presentation, which is located on the Investor section of the Lundbeck website. As you have heard, I'm joined by our CFO, Anders Götzsche and our EVP, R&D, Johan Luthman. Following our presentation, we will open the call for your questions.
On Slide 2, you can see the company's updated disclaimer. Please review this when you have the time. Please also refer to the cautionary statements regarding the transaction detailed in the
H Lundbeck A/S to Acquire Alder BioPharmaceuticals Inc Call Transcript
Sep 16, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers